E. Marielle Hijmans

E. Marielle Hijmans

Auto-generated profile, based on publicly available information

E. Marielle Hijmans

Division of Molecular Carcinogenesis, Oncode Institute, Cancer Genomics Center Netherlands, the Netherlands Cancer Institute, Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Cancer Cell
Verified
Journal Article
Closed access
KBKatrien Berns
Katrien Berns
HHHugo M. Horlings
Hugo M. Horlings
BHBryan T. Hennessy
Bryan T. Hennessy
MMMandy Madiredjo
Mandy Madiredjo
EHE. Marielle Hijmans
E. Marielle Hijmans
RBRené Bernards
René Bernards

25 March 2004 in Nature
Verified
Journal Article
Closed access
PDF file
KBKatrien Berns
Katrien Berns
EHE. Marielle Hijmans
E. Marielle Hijmans
JMJasper Mullenders
Jasper Mullenders
TBThijn R. Brummelkamp
Thijn R. Brummelkamp
AVArno Velds
Arno Velds
RBRené Bernards
René Bernards

15 November 1998 in Genes & Development
Verified
Journal Article
Open access
PDF file
RZRenate M.L. Zwijsen
Renate M.L. Zwijsen
RBRobin S. Buckle
Robin S. Buckle
EHE. Marielle Hijmans
E. Marielle Hijmans
CLCindy J.M. Loomans
Cindy J.M. Loomans
RBRené Bernards
René Bernards
The estrogen receptor (ER) is an important regulator of growth and differentiation of breast epithelium. Transactivation by ER depends on a leucine-rich motif, which constitutes a ligand-regulated binding site for steroid receptor coactivators (SRCs). Cyclin D1 is frequently amplified in breast cancer and can activate ER through direct binding. We show here that cyclin D1 also interacts in a ligand-independent fashion with coactivators of the SRC-1 family through a motif that resembles the leucine-rich coactivator binding motif of nuclear receptors. By acting as a bridging factor between ER and SRCs, cyclin D1 can recruit SRC-family coactivators to ER in the absence of ligand. A cyclin D1 mutant that binds to ER but fails to recruit coactivators preferentially interferes with ER activation in breast cancer cells that have high levels of cyclin D1. These data support that cyclin D1 contributes significantly to ER activation in breast cancers in which the protein is overexpressed. Our present results reveal a novel route of coactivator recruitment to ER and establish a direct role for cyclin D1 in regulation of transcription.

1 June 1995 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
EHE. Marielle Hijmans
E. Marielle Hijmans
PVP. Mathijs Voorhoeve
P. Mathijs Voorhoeve
RBRoderick L. Beijersbergen
Roderick L. Beijersbergen
LVLaura J. van 'T Veer
Laura J. van 'T Veer
RBRené Bernards
René Bernards
E2F DNA binding sites are found in a number of genes whose expression is tightly regulated during the cell cycle. The activity of E2F transcription factors is regulated by association with specific repressor molecules that can bind and inhibit the E2F transactivation domain. For E2F-1, E2F-2, and E2F-3, the repressor is the product of the retinoblastoma gene, pRb. E2f-4 interacts with pRb-related p107 and not with pRb itself. Recently, a cDNA encoding a third member of the retinoblastoma gene family, p130, was isolated. p130 also interacts with E2F DNA binding activity, primarily in the G0 phase of the cell cycle. We report here the cloning of a fifth member of the E2F gene family. The human E2F-5 cDNA encodes a 346-amino-acid protein with a predicted molecular mass of 38 kDa. E2F-5 is more closely related to E2F-4 (78% similarity) than to E2F-1 (57% similarity). E2F-5 resembles the other E2Fs in that it binds to a consensus E2F site in a cooperative fashion with DP-1. By using a specific E2F-5 antiserum, we found that under physiological conditions, E2F-5 interacts preferentially with p130.

10 May 2004 in Oncogene
Verified
Journal Article
Closed access
PDF file
NLNicola Logan
Nicola Logan
LDLaurent Delavaine
Laurent Delavaine
AGAnne Graham
Anne Graham
CRCarmel Reilly
Carmel Reilly
JWJon Wilson
Jon Wilson
NTNicholas B La Thangue
Nicholas B La Thangue

1 February 2005 in Genes & Development
Verified
Journal Article
Open access
PDF file
MCMenno P. Creyghton
Menno P. Creyghton
GRGiulietta Roël
Giulietta Roël
PEPieter Eichhorn
Pieter Eichhorn
EHE. Marielle Hijmans
E. Marielle Hijmans
IMIrma Maurer
Irma Maurer
RBRené Bernards
René Bernards
The Wnt signaling cascade is a central regulator of cell fate determination during embryonic development, whose deregulation contributes to oncogenesis. Naked cuticle is the first Wnt-induced antagonist found in this pathway, establishing a negative-feedback loop that limits the Wnt signal required for early segmentation. In addition, Naked cuticle is proposed to function as a switch, acting to restrict classical Wnt signaling and to activate a second Wnt signaling pathway that controls planar cell polarity during gastrulation movements in vertebrates. Little is known about the biochemical function of Naked cuticle or its regulation. Here we report that PR72, a Protein Phosphatase type 2A regulatory subunit of unknown function, interacts both physically and functionally with Naked cuticle. We show that PR72, like Naked cuticle, acts as a negative regulator of the classical Wnt signaling cascade, establishing PR72 as a novel regulator of the Wnt signaling pathway. Our data provide evidence that the inhibitory effect of Naked cuticle on Wnt signaling depends on the presence of PR72, both in mammalian cell culture and in Xenopus embryos. Moreover, PR72 is required during early embryonic development to regulate cell morphogenetic movements during body axis formation.